The Curies’ element: state of the art and perspectives on the use of radium in nuclear medicine
Open Access
- 10 November 2023
- journal article
- review article
- Published by Springer Nature in EJNMMI Radiopharmacy and Chemistry
- Vol. 8 (1) , 1-27
Abstract
Background: The alpha-emitter radium-223 (223Ra) is presently used in nuclear medicine for the palliative treatment of bone metastases from castration-resistant prostate cancer. This application arises from its advantageous decay properties and its intrinsic ability to accumulate in regions of high bone turnover when injected as a simple chloride salt. The commercial availability of [223Ra]RaCl2 as a registered drug (Xofigo®) is a further additional asset. Main body: The prospect of extending the utility of 223Ra to targeted α-therapy of non-osseous cancers has garnered significant interest. Different methods, such as the use of bifunctional chelators and nanoparticles, have been explored to incorporate 223Ra in proper carriers designed to precisely target tumor sites. Nevertheless, the search for a suitable scaffold remains an ongoing challenge, impeding the diffusion of 223Ra-based radiopharmaceuticals. Conclusion: This review offers a comprehensive overview of the current role of radium radioisotopes in nuclear medicine, with a specific focus on 223Ra. It also critically examines the endeavors conducted so far to develop constructs capable of incorporating 223Ra into cancer-targeting drugs. Particular emphasis is given to the chemical aspects aimed at providing molecular scaffolds for the bifunctional chelator approach.Keywords
This publication has 111 references indexed in Scilit:
- Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of DiseaseChemical Reviews, 2010
- Macrocyclic Receptor Exhibiting Unprecedented Selectivity for Light LanthanidesJournal of the American Chemical Society, 2009
- Alpha-particles for targeted therapyAdvanced Drug Delivery Reviews, 2008
- Realizing the potential of the Actinium-225 radionuclide generator in targeted alpha particle therapy applicationsAdvanced Drug Delivery Reviews, 2008
- Sterically stabilized liposomes as a carrier for α-emitting radium and actinium radionuclidesNuclear Medicine and Biology, 2004
- Stability constants of metal complexes of macrocyclic ligands with pendant donor groupsSupramolecular Chemistry, 1996
- Production of 133mBa for medical purposesThe International Journal of Applied Radiation and Isotopes, 1977
- Revised effective ionic radii and systematic studies of interatomic distances in halides and chalcogenidesActa Crystallographica Section A, 1976
- Thermodynamik der Metallkomplexbildung mit PolyoxadiazamacrocyclenHelvetica Chimica Acta, 1975
- Distribution of Radioactive Calcium, Strontium, Barium and Radium Following Intravenous Injection into a Healthy ManInternational Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine, 1968